Distribution of European clinical and phase III pipeline 2013 by indication
This statistic depicts the distribution of European clinical and phase III pipeline in 2013, by indication. Among all products in the clinical pipeline, some 31 percent were products concerning cancer. In the phase III pipeline, some 27 percent of products were for cancer.